Key result
Commercial IgM ELISAs showed moderate sensitivity for JEV in CSF, though Panbio sensitivity reached 96.2% using Ravi criteria, with high specificities.
Why the study?
What is the diagnostic accuracy of commercial IgM ELISAs compared to a reference standard for diagnosing Japanese Encephalitis Virus infections in patients with suspected CNS infections?
Observational (n=515)
No
What is the diagnostic accuracy of commercial IgM ELISAs compared to a reference standard for diagnosing Japanese Encephalitis Virus infections in patients with suspected CNS infections?
Commercial IgM ELISAs show moderate sensitivity but high specificity for diagnosing JEV in CSF, with sensitivity improving significantly when using specific criteria.
Answers are grounded in this paper and cite their sources.
Moderate CSF IgM ELISA sensitivity for JEV requires diagnostic caution; leaves open refinement of criteria and reference standards.
Japanese encephalitis virus (JEV) is a major cause of encephalitis in Asia. We estimated the diagnostic accuracy of two anti-JEV immunoglobulin M (IgM) enzyme-linked immunosorbent assays (ELISAs) (Panbio and XCyton JEVCheX) compared with a reference standard (AFRIMS JEV MAC ELISA) in a prospective study of the causes of central nervous system infections in Laos. Cerebrospinal fluid (CSF; 515 patients) and serum samples (182 patients) from those admitted to Mahosot Hospital, Vientiane, were tested. The CSF from 14.5% of acute encephalitis syndrome (AES) patients and 10.1% from those with AES and meningitis were positive for anti-JEV IgM in the reference ELISA. The sensitivities for CSF were 65.4% (95% confidence interval [CI] = 51-78) (Xcyton), 69.2% (95% CI = 55-81) (Panbio), however 96.2% (95% CI = 87-100) with Panbio Ravi criteria. Specificities were 89-100%. For admission sera from AES patients, sensitivities and specificities of the Panbio ELISA were 85.7% (95% CI = 42-100%) and 92.9% (95% CI = 83-98%), respectively.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2012) conducted an observational in Suspected central nervous system infections (n=515). Commercial anti-JEV IgM ELISAs (Panbio and XCyton JEVCheX) vs. AFRIMS JEV MAC ELISA (reference standard) was evaluated on Diagnostic sensitivity and specificity for JEV. Commercial IgM ELISAs showed moderate sensitivity for JEV in CSF, though Panbio sensitivity reached 96.2% using Ravi criteria, with high specificities.
Synapse has enriched 10 related papers. Consider them for comparative context: